Literature DB >> 35005327

The contribution of the cardiomyocyte to tissue inflammation in cardiomyopathies.

Van Kim Ninh1, Joan Heller Brown1.   

Abstract

Cardiac injury triggers an acute immune response that drives tissue healing and remodeling via the activation of compensatory mechanisms. Over time, remodeling and inflammation become chronic and have adverse effects that lead to a depression of cardiac function and eventual heart failure. Cardiac inflammation is characterized by dynamic spatial and temporal crosstalk between the resident cells of the heart and recruitment of circulating leukocytes. Until recently, the cardiomyocyte has not been accepted as a direct contributor to cardiac inflammation. It has now emerged as a key initiator of the acute immune response via its ability to produce cytokines and may also synchronize leukocyte recruitment post-injury. This review will focus on the role of the cardiomyocyte in the acute immune response to ischemic and non-ischemic injury and the mechanisms by which it may influence the course of cardiac remodeling and failure.

Entities:  

Year:  2020        PMID: 35005327      PMCID: PMC8730355          DOI: 10.1016/j.cophys.2020.10.003

Source DB:  PubMed          Journal:  Curr Opin Physiol        ISSN: 2468-8673


  53 in total

1.  Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling.

Authors:  Takeshi Suetomi; Andrew Willeford; Cameron S Brand; Yoshitake Cho; Robert S Ross; Shigeki Miyamoto; Joan Heller Brown
Journal:  Circulation       Date:  2018-11-27       Impact factor: 29.690

2.  Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33.

Authors:  Wei-Yu Chen; Jaewoo Hong; Joseph Gannon; Rahul Kakkar; Richard T Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

3.  Ca2+/calmodulin-dependent protein kinase II is essential in hyperacute pressure overload.

Authors:  Maria J Baier; Susanne Klatt; Karin P Hammer; Lars S Maier; Adam G Rokita
Journal:  J Mol Cell Cardiol       Date:  2019-12-10       Impact factor: 5.000

4.  Tissue Resident CCR2- and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury.

Authors:  Geetika Bajpai; Andrea Bredemeyer; Wenjun Li; Konstantin Zaitsev; Andrew L Koenig; Inessa Lokshina; Jayaram Mohan; Brooke Ivey; His-Min Hsiao; Carla Weinheimer; Attila Kovacs; Slava Epelman; Maxim Artyomov; Daniel Kreisel; Kory J Lavine
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 23.213

5.  CCR2+ Monocyte-Derived Infiltrating Macrophages Are Required for Adverse Cardiac Remodeling During Pressure Overload.

Authors:  Bindiya Patel; Shyam S Bansal; Mohamed Ameen Ismahil; Tariq Hamid; Gregg Rokosh; Matthias Mack; Sumanth D Prabhu
Journal:  JACC Basic Transl Sci       Date:  2018-03-14

6.  TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis.

Authors:  Fang-Yuan Liu; Di Fan; Zheng Yang; Nan Tang; Zhen Guo; Shu-Qing Ma; Zhen-Guo Ma; Hai-Ming Wu; Wei Deng; Qi-Zhu Tang
Journal:  Cell Death Dis       Date:  2019-06-17       Impact factor: 8.469

7.  Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-κB activation.

Authors:  John A Marwick; Ross Mills; Oliver Kay; Kyriakos Michail; Jillian Stephen; Adriano G Rossi; Ian Dransfield; Nikhil Hirani
Journal:  Cell Death Dis       Date:  2018-06-04       Impact factor: 8.469

8.  Inflammation leads through PGE/EP3 signaling to HDAC5/MEF2-dependent transcription in cardiac myocytes.

Authors:  András D Tóth; Richard Schell; Magdolna Lévay; Christiane Vettel; Philipp Theis; Clemens Haslinger; Felix Alban; Stefanie Werhahn; Lina Frischbier; Jutta Krebs-Haupenthal; Dominique Thomas; Hermann-Josef Gröne; Metin Avkiran; Hugo A Katus; Thomas Wieland; Johannes Backs
Journal:  EMBO Mol Med       Date:  2018-07       Impact factor: 12.137

9.  IRF3 and type I interferons fuel a fatal response to myocardial infarction.

Authors:  Kevin R King; Aaron D Aguirre; Yu-Xiang Ye; Yuan Sun; Jason D Roh; Richard P Ng; Rainer H Kohler; Sean P Arlauckas; Yoshiko Iwamoto; Andrej Savol; Ruslan I Sadreyev; Mark Kelly; Timothy P Fitzgibbons; Katherine A Fitzgerald; Timothy Mitchison; Peter Libby; Matthias Nahrendorf; Ralph Weissleder
Journal:  Nat Med       Date:  2017-11-06       Impact factor: 53.440

10.  SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.

Authors:  Xavier Palomer; M Silvia Román-Azcona; Javier Pizarro-Delgado; Ana Planavila; Francesc Villarroya; Brenda Valenzuela-Alcaraz; Fátima Crispi; Álvaro Sepúlveda-Martínez; Irene Miguel-Escalada; Jorge Ferrer; J Francisco Nistal; Raquel García; Mercy M Davidson; Emma Barroso; Manuel Vázquez-Carrera
Journal:  Signal Transduct Target Ther       Date:  2020-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.